Altimmune, Inc. ( ALT) - Stock Earnings
ALT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -19.0 million USD | 5000 USD |
| 2025Q4 | -27.4 million USD | 26000 USD |
| 2026Q1 | -22.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ALT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -88.4 million USD | 426000 USD |
| 2024 | -95.1 million USD | 20000 USD |
| 2025 | -88.1 million USD | 41000 USD |
| 2026 Est. | — | — |
ALT
Price: $2.62
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.92 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 680703
Ebitda: -31.4 millionMarket Capitalization: 253.3 million